ARCHIVES

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

United Approach With Other Health Advocates Needed To Increase Cancer Dollars, Royboal Says

February 10, 1978

DCBD Board Votes down, Then Approves Organ Systems PA

November 10, 1989

ACS Urges Practice Of Insurance Exclusion End Under Reform

February 5, 1993

Republican Contenders Slam FDA Decision In Care Of Boy With Treatable Brain Tumor.

February 4, 2000

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

March 29, 2013

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

April 4, 1996